Teva Pharmaceutical Industries Limited (TEVA) Investment Research Dashboard
About Teva Pharmaceutical Industries Limited (TEVA) stock analysis
Get live TEVA stock price $31.67, comprehensive Teva Pharmaceutical Industries Limited stock analysis, charts, news, sentiment, sector analysis, and expert forecast. Real-time TEVA stock data and investment insights.
Loading chart data...
Teva Pharmaceutical Industries Limited (TEVA) Overview
Teva Pharmaceutical Industries Limited (TEVA) is a publicly traded company in the Healthcare sector , specifically within the Drug Manufacturers - Specialty & Generic industry . As of the latest trading session, TEVA trades at $31.67 with a market capitalization of 36.88B . Over the past 52 weeks, TEVA has traded between $14.99 and $37.35 , with the current price positioned at approximately 75%...
Key Takeaways
- Operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic)
- Market cap: 36.88B
- Current price: $31.67
- 52-week range: $14.99 - $37.35
- P/E ratio: 10.81
Investment Score
A systematic tri-factor framework (valuation, quality, momentum) using trailing twelve-month fundamentals and current price momentum—aligned with the full investment score dashboard.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
Teva Pharmaceutical Industries Limited functions as a global pharmaceutical enterprise, involved in the conception, manufacturing, marketing, and provision of a broad spectrum of generic, specialty, and biopharmaceutical products throughout North Ame...
Company Information
- CEO
- Richard D. Francis
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Employees
- 37000
Contact Information
- Website
- https://www.tevapharm.com
- Address
- 124 Dvora Hanevi'a Street
- Country
- IL
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Valuation metrics suggest potential value opportunity (P/E: 10.8)
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Teva Pharmaceutical Industries Limited shareholders
- ⚠Market volatility can significantly impact stock price, especially for mid-cap stocks
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Teva Pharmaceutical Industries Limited
- ⚠Investors should consider how Teva Pharmaceutical Industries Limited fits within their overall portfolio allocation
- ⚠Valuation metrics suggest potential, but require fundamental analysis
Market Cap
36.88B
P/E Ratio (TTM)
10.81
Beta
0.86
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare TEVA with peer companies:
- Price
- $205.61+2.73% (1D)
- Market cap
- 30.36B
- Price
- $92.45+1.49% (1D)
- Market cap
- 23.38B
- Price
- $74.85+2.02% (1D)
- Market cap
- 28.88B
- Price
- $314.23+4.34% (1D)
- Market cap
- 25.77B
- Price
- $182.83+3.64% (1D)
- Market cap
- 18.38B
- Price
- $252.22-2.25% (1D)
- Market cap
- 36.12B
- Price
- $25.55+2.12% (1D)
- Market cap
- 24.82B
- Price
- $167.47+1.50% (1D)
- Market cap
- 11.60B
- Price
- $230.34+5.47% (1D)
- Market cap
- 22.45B
- Price
- $383.90+3.42% (1D)
- Market cap
- 25.02B
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.
Healthcare (1D)
78/100 ⭐⭐⭐⭐⭐
- Overall
- +0.7%
- NYSE
- +0.6%
- NASDAQ
- +0.7%
| Sector | 1D | 1W | 1M | P/E | Score |
|---|---|---|---|---|---|
| Financial Services | +2.2% | +3.1% | +4.3% | 19.3 | 98/100⭐⭐⭐⭐⭐ |
| Healthcare | +0.7% | +1.3% | +1.6% | 24.1 | 78/100⭐⭐⭐⭐⭐ |
| Communication Services | +1.4% | -0.7% | +2.9% | 22.2 | 74/100⭐⭐⭐⭐⭐ |
| Consumer Defensive | -0.2% | +1.8% | +0.7% | 29.8 | 64/100⭐⭐⭐⭐ |
| Basic Materials | +0.4% | +1.2% | -0.2% | 25.2 | 61/100⭐⭐⭐⭐ |
| Real Estate | -0.5% | +0.0% | -2.4% | 29.2 | 46/100⭐⭐⭐ |
| Energy | -2.1% | -3.7% | -4.1% | 19.1 | 39/100⭐⭐ |
| Utilities | -1.0% | +0.0% | -4.4% | 26.8 | 35/100⭐⭐ |
| Industrials | +0.6% | +0.4% | -9.9% | 30.1 | 23/100⭐ |
| Consumer Cyclical | +0.5% | -1.5% | -5.8% | 43.0 | 18/100⭐ |
| Technology | +0.6% | -1.6% | -7.2% | 40.7 | 15/100⭐ |
Sector returns combine NYSE and NASDAQ averages. P/E is the latest blended sector multiple. Sector score ranks each sector vs peers using percentile ranks (not fixed thresholds): 48% 1M + 24% 1W + 8% 1D + 20% P/E (lower P/E ranks higher). Data as of 2026-07-28.